Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet treatment for managing HIV infection. This formula integrates three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to multiply within the body, considerably reducing the viral quantity.